Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 30, 2007

Laureate Pharma to Manufacture Trubion’s Cancer Candidate

  • Laureate Pharma will produce Trubion Pharmaceuticals’ non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) drug candidate. TRU-016 targets CD37, an antigen present on B cells.

    The company expects to file an IND for TRU-016 in the second half of 2007 after completing preclinical testing.
    Trubion currently retains all development and commercialization rights for the TRU-016 program.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »